核受体
受体
生物
脂质代谢
肝X受体
法尼甾体X受体
碳水化合物代谢
内分泌学
内科学
胰岛素
葡萄糖稳态
新陈代谢
胰岛素抵抗
胰岛素受体
脂肪肝
代谢综合征
脂肪生成
生物化学
医学
糖尿病
转录因子
基因
作者
Demin Cai,Haoyu Liu,Ruqian Zhao
出处
期刊:Current Protein & Peptide Science
[Bentham Science]
日期:2017-04-17
卷期号:18 (6): 548-561
被引量:5
标识
DOI:10.2174/1389203717666160627081751
摘要
Research efforts focusing on metabolic diseases have established a close conjunction between glucolipid abnormalities and nuclear receptors, a large superfamily of receptors including classic peroxisome proliferation-activated receptors (PPARs), liver X receptors (LXRs), farnesoid X receptors (FXRs) and glucocorticoid receptors (GRs) together with burgeoning retinoic acid receptor-related orphan receptors (RORs) and REV-ERBs. Nuclear receptors are identified to control a series of physiological and pathological processes of glucose and lipid metabolism and also implicated to mediate the long-term effects of early environmental and nutritional experiences on the formation of adult chronic metabolic disorders in human and animals. Thus, nuclear receptors play profound roles in fetal programming and adult regulation of glucolipid metabolism. In this review, we provide an overview on the recent advances in the field of nuclear receptors focusing on their roles in lipid and glucose metabolism during early and late life courses. We hope that this knowledge may shed new lights on identifying the novel target molecules or pathways for the prevention and treatment of metabolic disorders involving disrupted glucose and lipid homeostasis in human and animals.
科研通智能强力驱动
Strongly Powered by AbleSci AI